We are excited to present the Q-CROC 2022 Activity Report, which covers a year full of concrete achievements that demonstrate our leadership and creativity in supporting clinical oncology research in Quebec.
As we approach our 15th anniversary, we firmly believe that our nonprofit is more relevant than ever and look forward to continuing our work with the entire Quebec community and beyond.
– Jean-Frédéric Lafontaine (Chair) et Lucie D’Amours (General Manager)
Thanks to all of our funding partners that have made our projects possible: Amgen, AbbVie, AstraZeneca, Bristol Meyers-Squibb, Gilead, GlaxoSmithKline, Merck, Novocure, Oncopole and Pfizer.
Click here to view the English version.
Une version française du rapport d’activité 2022 est aussi disponible.